de Melo Bruno Pereira, da Silva Jhéssica Adriane Mello, Rodrigues Mariana Alves, Palmeira Julys da Fonseca, Amato Angélica Amorim, Argañaraz Gustavo Adolfo, Argañaraz Enrique Roberto
Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasília 70910-900, DF, Brazil.
Laboratory of Molecular Pharmacology, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
SARS-CoV-2 infection has had a significant impact on global health through both acute illness, referred to as coronavirus disease 2019 (COVID-19), and chronic conditions (long COVID or post-acute sequelae of COVID-19, PASC). Despite substantial advancements in preventing severe COVID-19 cases through vaccination, the rise in the prevalence of long COVID syndrome and a notable degree of genomic mutation, primarily in the S protein, underscores the necessity for a deeper understanding of the underlying pathophysiological mechanisms related to the S protein of SARS-CoV-2. In this review, the latest part of this series, we investigate the potential pathophysiological molecular mechanisms triggered by the interaction between the spike protein and cellular receptors. Therefore, this review aims to provide a differential and focused view on the mechanisms potentially activated by the binding of the spike protein to canonical and non-canonical receptors for SARS-CoV-2, together with their possible interactions and effects on the pathogenesis of long COVID.
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染通过急性疾病(称为2019冠状病毒病,COVID-19)和慢性疾病(长期COVID或COVID-19急性后遗症,PASC)对全球健康产生了重大影响。尽管通过接种疫苗在预防严重COVID-19病例方面取得了重大进展,但长期COVID综合征患病率的上升以及主要在刺突蛋白中出现的显著程度的基因组突变,凸显了深入了解与SARS-CoV-2刺突蛋白相关的潜在病理生理机制的必要性。在本系列的最新这篇综述中,我们研究了刺突蛋白与细胞受体相互作用引发的潜在病理生理分子机制。因此,本综述旨在对刺突蛋白与SARS-CoV-2的经典和非经典受体结合可能激活的机制,以及它们对长期COVID发病机制的可能相互作用和影响,提供一个有区别且重点突出的观点。